1390P Efficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials

Citation

• Kaasa, S., Laird, B., Fallon, M., McMillan, D., Skipworth, R., Currow, D., & Giorgino, R. (2017). 1390P Efficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials. Annals of Oncology, 28, v498. doi:10.1093/annonc/mdx382.005

Digital Object Identifier (doi)

• 10.1093/annonc/mdx382.005

Web Of Science Accession Number

Start Page

• v498

Volume

• 28

Issue

Place Of Publication

Abstract

UOW Authors

•   Currow, David

Publication Date

• 2017

Publisher

• Elsevier 

Published In

• Annals of Oncology  Journal

Citation

• Kaasa, S., Laird, B., Fallon, M., McMillan, D., Skipworth, R., Currow, D., & Giorgino, R. (2017). 1390P Efficacy of anamorelin in advanced non-small cell lung cancer (NSCLC) patients with anorexia/cachexia and modified Glasgow Prognostic Score (mGPS) of 2: Pooled analysis of two phase 3 trials. Annals of Oncology, 28, v498. doi:10.1093/annonc/mdx382.005

Digital Object Identifier (doi)

• 10.1093/annonc/mdx382.005

Web Of Science Accession Number

Start Page

• v498

Volume

• 28

Issue

Place Of Publication